Armata Pharmaceuticals, Inc.
ARMP
$5.41
-$0.41-7.05%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -192.18M | -282.61M | -173.80M | -46.90M | -25.71M |
| Total Depreciation and Amortization | 1.84M | 1.61M | 1.53M | 1.49M | 1.44M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 165.15M | 256.35M | 147.92M | 18.58M | -4.37M |
| Change in Net Operating Assets | -230.00K | 684.00K | -1.41M | -190.00K | -2.94M |
| Cash from Operations | -25.42M | -23.97M | -25.76M | -27.02M | -31.58M |
| Capital Expenditure | -374.00K | -506.00K | -542.00K | -413.00K | -511.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -374.00K | -506.00K | -542.00K | -413.00K | -511.00K |
| Total Debt Issued | 40.00M | 15.00M | 25.00M | 25.00M | 10.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.24M | 1.36M | 658.00K | 0.00 | 0.00 |
| Repurchase of Common Stock | -95.00K | -95.00K | -46.00K | -46.00K | -75.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 44.15M | 16.27M | 25.61M | 24.95M | 9.93M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.35M | -8.20M | -693.00K | -2.48M | -22.17M |